N-[2-(diisopropylamino)ethyl]-2-oxo-1-pyrrolidineacetamide CAS NO.68497-62-1

Product introduction

Pramiracetam is a brain metabolism enhancement drug of pyrrolidone, which is a central nervous drug that can improve memory and anti-forgetfulness. Developed by Parke-Davis Pharmaceutical Company in the United States, Pramiracetam has a strong ability to improve brain function, enhance memory and promote brain alertness. Clinical experiments have proved that its activity is 6-13 times that of piracetam (cerebral rehabilitation). It is 3-4 times as much as oxacetam and 1.25 times as much aniracetam. With low toxicity and good tolerance, it can be used for long-term medication to improve symptoms and delay Alzheimer's dementia. Clinically suitable for the elderly attention and memory disorders, benign aging forgetfulness, senile dementia (Alzheimer's disease) prevention, memory enhancement. Pramiracetam is also used as an additive in health care products for body building and vascular dilation.

Feature

Pramiracetam works by increasing the release of the neurotransmitter acetylcholine to improve cognitive function in the brain. It can also increase the number and connectivity of neurons, promoting neuron growth and repair. Pramiracetam can also increase the metabolic rate of the brain and increase cerebral blood flow, thereby improving the oxygen and nutrient supply to the brain. Pramiracetam is widely used to treat problems such as cognitive impairment, memory loss, inattention, and learning difficulties. It is also used to improve athletic performance and reduce symptoms of anxiety and depression.

Applications

Pramiracetam is a potent nootropic agent that is a member of the racetam drug family. Pramiracetam improves cognitive deficits associated with traumatic brain injuries. Also, pramiracetam is a specific inhibitor of prolyl endopeptidase. Pramiracetam plays an important role in spatial learning and memory in rats.It is considered as a memory enhancing agent and is stronger than piracetam.